Page last updated: 2024-08-22

vidarabine and Peripheral Nerve Diseases

vidarabine has been researched along with Peripheral Nerve Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19904 (40.00)18.7374
1990's2 (20.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaudhry, HM; Mauermann, ML; Rajkumar, SV1
Caballero, D; Caballero-Velázquez, T; Castilla-Llorente, C; Encinas, C; Heras, I; López-Corral, L; Martino, R; Pérez-Simón, JA; Rosiñol, L; Sampol, A; San Miguel, J; Serrano, D1
Aleric, I; Bakovic, M; Bilic, E; Ceovic, R; Curtis, LM; Delimar, V; Desnica, L; Milos, O; Nemet, D; Pavletic, SZ; Pulanic, D; Pulanic, TK; Seiwerth, RS; Stipetic, MM; Vrhovac, R1
Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN1
Bady, B; Brunon, AM; Chauplannaz, G; Trepo, C2
Fray, R; Handler, CE; Perkin, GD; Woinarski, J1
Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Plunkett, W; Rios, MB1
Hughes, RA; Lunn, MP; Schey, S; Wilson, HC1
Berlit, P; Brosi, K; Krause, KH; Raedsch, R; Scheglmann, K1

Reviews

1 review(s) available for vidarabine and Peripheral Nerve Diseases

ArticleYear
Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
    Mayo Clinic proceedings, 2017, Volume: 92, Issue:5

    Topics: Administration, Intravenous; Biomarkers; Demyelinating Autoimmune Diseases, CNS; Diagnosis, Differential; Glycoproteins; Humans; Immunoglobulins; Immunologic Factors; Monoclonal Gammopathy of Undetermined Significance; Myeloablative Agonists; Peripheral Nervous System Diseases; Plasmapheresis; Prognosis; Rituximab; Vidarabine

2017

Trials

2 trial(s) available for vidarabine and Peripheral Nerve Diseases

ArticleYear
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
    British journal of haematology, 2013, Volume: 162, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclosporine; Drug Synergism; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Pyrazines; Remission Induction; Reoperation; Salvage Therapy; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Vidarabine

2013
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:4-5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Colitis; Combined Modality Therapy; Conjunctivitis; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine

1993

Other Studies

7 other study(ies) available for vidarabine and Peripheral Nerve Diseases

ArticleYear
High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD.
    Bone marrow transplantation, 2016, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Cohort Studies; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Prevalence; Prospective Studies; Small Fiber Neuropathy; Vidarabine; Young Adult

2016
Fatal peripheral neuropathy following FLA chemotherapy.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:4

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole

2004
[Neuropathy following treatment of chronic active hepatitis with vidarabine].
    Revue neurologique, 1984, Volume: 140, Issue:12

    Topics: Adult; Electrophysiology; Hepatitis, Chronic; Humans; Male; Peripheral Nervous System Diseases; Vidarabine

1984
Radiculomyelopathy associated with herpes simplex genitalis treated with adenosine arabinoside.
    Postgraduate medical journal, 1983, Volume: 59, Issue:692

    Topics: Adult; Female; Herpes Genitalis; Humans; Male; Peripheral Nervous System Diseases; Spinal Cord Diseases; Spinal Nerve Roots; Vidarabine

1983
Successful treatment of IgM paraproteinaemic neuropathy with fludarabine.
    Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:5

    Topics: Aged; Aged, 80 and over; Female; Humans; Immunoglobulin M; Immunosuppressive Agents; Male; Middle Aged; Paraproteinemias; Peripheral Nervous System Diseases; Vidarabine

1999
[Polyneuropathy following treatment of chronic hepatitis B with vidarabine].
    Deutsche medizinische Wochenschrift (1946), 1988, Apr-29, Volume: 113, Issue:17

    Topics: Adult; Electromyography; Female; Follow-Up Studies; H-Reflex; Hepatitis B; Humans; Median Nerve; Neural Conduction; Peripheral Nervous System Diseases; Tibial Nerve; Time Factors; Vidarabine

1988
[Neurotoxicity of vidarabine in chronic active hepatitis].
    Presse medicale (Paris, France : 1983), 1985, May-18, Volume: 14, Issue:20

    Topics: Hepatitis, Chronic; Humans; Peripheral Nervous System Diseases; Vidarabine

1985